Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$36.81 - $48.12 $2.76 Million - $3.61 Million
75,000 New
75,000 $3.1 Million
Q3 2022

Nov 14, 2022

SELL
$42.51 - $54.02 $13.3 Million - $16.9 Million
-312,200 Reduced 40.6%
456,700 $20 Million
Q2 2022

Aug 15, 2022

BUY
$46.84 - $59.75 $13.2 Million - $16.8 Million
281,644 Added 57.8%
768,900 $37.8 Million
Q1 2022

May 16, 2022

BUY
$48.09 - $57.79 $23.4 Million - $28.2 Million
487,256 New
487,256 $27.6 Million
Q4 2021

Feb 14, 2022

SELL
$47.19 - $62.68 $8.01 Million - $10.6 Million
-169,800 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$56.91 - $67.81 $9.66 Million - $11.5 Million
169,800 New
169,800 $10.2 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Polar Asset Management Partners Inc. Portfolio

Follow Polar Asset Management Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Polar Asset Management Partners Inc. with notifications on news.